Drug Database · Clinicians

Sodium valproate + Valproic acid

Brands (3) Encorate Chrono 500, Valparin XR 500, ValprosShow all

Antiepileptic; Anticonvulsant/Antiepileptic PH FDA category
Fixed-dose combination.

Rx · Prescription drug5 PH productsPNF-listed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Monotherapy and adjunctive therapy of complex partial seizures; sole and adjunctive therapy of simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Controlled-release tablet: 333 mg/145 mg, 500 mg

Registered products in the Philippines

5 products registered with the Food and Drug Administration (FDA) Philippines list Sodium valproate + Valproic acid as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products5
Philippine FDA-registered products for Sodium valproate + Valproic acid
Package insert
Encorate Chrono 500Sodium Valproate + Valproic Acid
333 mg/145 mg Controlled Release TabletAlu/Alu Blister Pack x 10's (Box of 50's)
Rx
Sun Pharma Laboratories LimitedIndia
Sun Pharma Philippines, Inc.
DRP-10110
Apr 23, 2029
Encorate Chrono 500Sodium Valproate + Valproic Acid (as sodium valproate)
333 mg/145 mg Controlled-Release TabletStrip Foil x 10's (Box of 50's)
Rx
Sun Pharma Laboratories Ltd.India
Sun Pharma Philippines, Inc.
DRP-9908
Aug 1, 2030
NoneSodium Valproate + Valproic Acid
333 mg / 145 mg Controlled Release TabletAlu/Alu Blister Pack x 10’s (Box of 50’s)
Rx
Sun Pharma Laboratories LimitedIndia
Ritemed Phils., Inc.Importer: Sun Pharma Philippines, Inc.
DRP-10110-02
Apr 23, 2029
Valparin XR 500Sodium Valproate + Valproic Acid
500 mg Controlled-Release TabletAluminum Foil Strip x 10's (Box of 100's)
Rx
Torrent Pharmaceuticals Ltd.India
Torrent Pharma Philippines Inc.
DRP-2768
Mar 13, 2032
ValprosSodium Valproate + Valproic Acid
500 mg Controlled-Release TabletAlu/Alu Blister Pack x 10's (Box of 30's)
Rx
Intas Pharmaceuticals Ltd.India
UNILAB, Inc.
DR-XY38389
Aug 19, 2030

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Valproate Disodium/Valproic Acid 250 mg Tablet₱7.95–₱27.50Reference ₱8.88per tabletDPRI procurement range
Valproate Disodium/Valproic Acid 500 mg Film coated tablet₱7.20–₱39.60Reference ₱10.75per tabletDPRI procurement range
Valproic Acid + Sodium Valproate 500 mg MR Tablet₱10.75–₱11.95Reference ₱10.75per tabletDPRI procurement range

Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Sodium Valproate + Valproic Acid
PNF listingOral: 500 mg (333 mg sodium valproate + 145 mg valproic acid) controlled releasetablet
PNF listingOral: 500 mg (333 mg sodium valproate + 145 mg valproic acid) controlled release tablet
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  2. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  3. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .